Evaluation of a patient event report monitoring system

Pharmacoepidemiology and Drug Safety

Volumn 9, Issue 6, 2000, Pages 491-499

  Colebatch, Karen A ^a   Marley, John ^b   Doecke, Christopher ^a   Miles, HelenB ^b   Gilbert, Andrew ^c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Adverse drug reaction; Pharmacoepidemiology; Postmarketing surveillance

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG; HORMONE;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CONSULTATION; EVALUATION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NURSE; PATIENT MONITORING; PATIENT SELECTION; PHARMACIST; PHARMACY; PRIORITY JOURNAL; SELF REPORT; TEACHING HOSPITAL;

EID: 0034519018     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1557(200011)9:6<491::AID-PDS532>3.0.CO;2-O     Document Type: Article

References (16)

1. Incidence of adverse drug reactions in hospitalized patients
2. Recognizing and reporting adverse drug reactions
3. Post-marketing surveillance of drugs. The spontaneous reporting scheme: Role of the Adverse Drug Reactions Advisory Committee
4. Experience in the development of a postmarketing surveillance network: The Pharmacy Medication Monitoring Program
5. Measuring the frequency of adverse drug reactions
6. An introduction to ADRs
7. Spontaneous adverse drug reaction reporting vs. event reporting vs. event monitoring: A comparison
8. Requirements for risk benefit assessment of drugs before withdrawal
9. Adverse Drug Reactions: Can consumers provide early warning?
10. Patients as a direct source of information on adverse drug reactions
11. Postmarketing surveillance: Accuracy of patient drug attribution judgments
12. A methodologic study of post-marketing drug evaluation using a pharmacy-based approach
13. Patient drug attributions and postmarketing surveillance
14. Postmarketing surveillanc by patient self-monitoring: Preliminary data for sertraline versus fluoxetine
15. Does communication between investigators improve the conduct of the multicentre study?
16. Drug-induced illness leading to hospitalisation